1. Home
  2. ABOS vs RMNI Comparison

ABOS vs RMNI Comparison

Compare ABOS & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • RMNI
  • Stock Information
  • Founded
  • ABOS 1996
  • RMNI 2005
  • Country
  • ABOS United States
  • RMNI United States
  • Employees
  • ABOS N/A
  • RMNI N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • RMNI Business Services
  • Sector
  • ABOS Health Care
  • RMNI Consumer Discretionary
  • Exchange
  • ABOS Nasdaq
  • RMNI Nasdaq
  • Market Cap
  • ABOS 166.4M
  • RMNI 163.3M
  • IPO Year
  • ABOS 2021
  • RMNI N/A
  • Fundamental
  • Price
  • ABOS $2.47
  • RMNI $1.83
  • Analyst Decision
  • ABOS Strong Buy
  • RMNI Hold
  • Analyst Count
  • ABOS 4
  • RMNI 1
  • Target Price
  • ABOS $9.00
  • RMNI N/A
  • AVG Volume (30 Days)
  • ABOS 180.2K
  • RMNI 176.3K
  • Earning Date
  • ABOS 08-13-2024
  • RMNI 10-30-2024
  • Dividend Yield
  • ABOS N/A
  • RMNI N/A
  • EPS Growth
  • ABOS N/A
  • RMNI 340.37
  • EPS
  • ABOS N/A
  • RMNI 0.18
  • Revenue
  • ABOS N/A
  • RMNI $429,431,000.00
  • Revenue This Year
  • ABOS N/A
  • RMNI N/A
  • Revenue Next Year
  • ABOS N/A
  • RMNI N/A
  • P/E Ratio
  • ABOS N/A
  • RMNI $10.02
  • Revenue Growth
  • ABOS N/A
  • RMNI 1.64
  • 52 Week Low
  • ABOS $1.81
  • RMNI $1.55
  • 52 Week High
  • ABOS $5.73
  • RMNI $3.44
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 43.40
  • RMNI 44.52
  • Support Level
  • ABOS $2.15
  • RMNI $1.70
  • Resistance Level
  • ABOS $2.92
  • RMNI $1.85
  • Average True Range (ATR)
  • ABOS 0.17
  • RMNI 0.09
  • MACD
  • ABOS -0.02
  • RMNI 0.04
  • Stochastic Oscillator
  • ABOS 37.14
  • RMNI 50.00

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc is a provider of enterprise software support products and services and a third-party support provider for Oracle and SAP software products based in the United States. The company offers solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. Some of its products include Oracle E-business suite, Oracle Database, Peoplesoft, SAP business suite, and others. The company derives maximum revenue from United states.

Share on Social Networks: